Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Common Stock | Options Exercise | +72.4K | +136.69% | 125K | Mar 27, 2024 | Direct | F1 | ||
transaction | LH | Common Stock | Tax liability | -$6.89M | -31.8K | -25.35% | $216.57 | 93.6K | Mar 27, 2024 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Restricted Stock Unit | Options Exercise | -72.4K | -76.03% | 22.8K | Mar 27, 2024 | Common Stock | 72.4K | Direct | F1, F3, F4 |
Id | Content |
---|---|
F1 | Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. |
F2 | Stock withholding to satisfy tax withholding obligations. |
F3 | As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024. |
F4 | This number reflects the aggregate number of RSUs held by the reporting person. |